Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.42 |
| ▸ | PLAU | P00749 | 1/20 | 0.42 |
| ▸ | PTPRC | P08575 | 1/20 | 0.42 |
| ▸ | S100A4 | P26447 | 1/20 | 0.42 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30487743 | 1.00 | ALDH1A1 (0.53) | ALDH1A1CYP1A2HSD17B10TSHRTDP1 | |
| SCHEMBL30100732 | 1.00 | ALDH1A1 (0.53) | ALDH1A1CYP1A2HSD17B10TSHRTDP1 | |
| SCHEMBL31134288 | 1.00 | ALDH1A1 (0.53) | ALDH1A1CYP1A2HSD17B10TSHRTDP1 | |
| SCHEMBL16011382 | 1.00 | ALDH1A1 (0.53) | ALDH1A1CYP1A2HSD17B10TSHRTDP1 | |
| Hydrochloric Acid SCHEMBL20521483 | 0.98 | ALDH1A1 (0.51) | ALDH1A1CYP1A2HSD17B10TSHRTDP1 | |
| Hydrochloric Acid SCHEMBL2890849 | 0.98 | ALDH1A1 (0.51) | ALDH1A1CYP1A2HSD17B10TSHRTDP1 | |
| SCHEMBL7775829 | 0.83 | CYP1A2 (0.58) | ALDH1A1CYP1A2HSD17B10TSHRTDP1 | |
| SCHEMBL16284318 | 0.83 | ALDH1A1 (0.56) | ALDH1A1CYP1A2HSD17B10TSHRTDP1 | |
| SCHEMBL18912100 | 0.83 | CYP1A2 (0.53) | ALDH1A1CYP1A2HSD17B10TSHRTDP1 | |
| SCHEMBL16687493 | 0.83 | ALDH1A1 (0.56) | ALDH1A1CYP1A2HSD17B10TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118806889-A | Method for improving adsorption of polysaccharide-protein conjugates and multivalent vaccine formulations obtained therefrom | 印度血清研究所私人有限公司 | 2024-10-22 | — | — | CN | claimed |
| EP-4025246-A2 | IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF | Serum Institute Of India Private Limited (IN) | 2022-07-13 | — | — | EP | claimed |
| CN-114728053-A | Immunogenic compositions against intestinal disease and process for preparing same | 印度血清研究所私人有限公司 | 2022-07-08 | — | — | CN | claimed |
| WO-2021044436-A2 | IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2021-03-11 | — | — | WO | claimed |
| EP-2254890-A1 | PROCESS FOR THE DIASTEREOISOMERIC RESOLUTION OF 5-METHYLTETRAHYDROFOLIC ACID | Gnosis S.p.A. (IT) | 2010-12-01 | — | — | EP | claimed |
| WO-2009103333-A1 | PROCESS FOR THE DIASTEREOISOMERIC RESOLUTION OF 5-METHYLTETRAHYDROFOLIC ACID | GNOSIS S.P.A. (IT) | 2009-08-27 | — | — | WO | claimed |
| EP-1476197-A2 | SYNTHESIS OF LIPOPOLYSACCHARIDE-PROTEIN CONJUGATE VACCINES VIA THE LIPID A REGION FOLLOWING REMOVAL OF THE GLYCOSIDIC PHOSPHATE RESIDUE | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2004-11-17 | — | — | EP | claimed |
| WO-2003070282-A2 | SYNTHESIS OF LIPOPOLYSACCHARIDE-PROTEIN CONJUGATE VACCINES VIA THE LIPID A REGION FOLLOWING REMOVAL OF THE GLYCOSIDIC PHOSPHATE RESIDUE | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2003-08-28 | — | — | WO | claimed |
| JP-7109250-A | — | — | None | — | — | JP | disclosed |
| US-12509431-B2 | 1,4-dihydroquinazolinone compounds and uses thereof | EDGEWISE THERAPEUTICS, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250361213-A1 | 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF | EDGEWISE THERAPEUTICS INC (US) | 2025-11-27 | — | — | US | disclosed |
| EP-4594307-A1 | 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF | EDGEWISE THERAPEUTICS, INC. (US) | 2025-08-06 | — | — | EP | disclosed |
| US-20250154111-A1 | 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF | EDGEWISE THERAPEUTICS, INC. | 2025-05-15 | — | — | US | disclosed |
| CN-119822969-A | Method for continuously preparing 4-nitrophenethylamine and salt thereof | 浙江华海药业股份有限公司 | 2025-04-15 | — | — | CN | disclosed |
| EP-0107149-B1 | NOVEL NAPHTHALENE DERIVATIVES AND METHOD FOR PREPARATION THEREOF | Tanabe Seiyaku Co., Ltd. (JP) | 1985-10-16 | — | — | EP | disclosed |
| US-4508882-A | ULTRAVIOLET ADSORBERS | ASAHI GLASS COMPANY LTD. (JP) | 1985-04-02 | — | — | US | disclosed |
| EP-0107149-A1 | Novel naphthalene derivatives and method for preparation thereof | Tanabe Seiyaku Co., Ltd. (JP) | 1984-05-02 | — | — | EP | disclosed |
| US-4380643-A | Benzotriazole compound and homopolymer or copolymers thereof | ASAHI GLASS COMPANY, LTD. (JP) | 1983-04-19 | — | — | US | disclosed |
| US-4374061-A | ACTIVATION, AMINATION, AND DIAZOTIZATION OF A POLYSACCHARIDE FOLLOWED BY REACTION WITH A GLOBULIN; CHROMATOGRAPHY; SEPARATION OF GLYCOPROTEINS | CENTER FOR BLOOD RESEARCH, INC. (US) | 1983-02-15 | — | — | US | disclosed |
| US-3995059-A | CHOLESTEROL LOWERING AGENTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509431-B2 | 1,4-dihydroquinazolinone compounds and uses thereof | TNNT2, TNNI3, TNNC1 | ALDH1A1 716/4885CYP1A2 942/4885HSD17B10 16/4885 |
| US-20250154111-A1 | 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF | TNNI3, TNNT2, SDHA | ALDH1A1 780/4885CYP1A2 1264/4885HSD17B10 130/4885 |
| US-20250361213-A1 | 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF | TNNI3, TNNT2, SDHA | ALDH1A1 780/4885CYP1A2 1264/4885HSD17B10 130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.